Skip to main content
SpringerLink
Log in

Noninvasive imaging of apoptosis in cardiovascular disease

  • Published:
Heart Failure Reviews Aims and scope Submit manuscript

Abstract

Recent advances in molecular imaging have permitted the noninvasive imaging of apoptosis, a critical process underlying the pathogenesis of many diseases of the cardiovascular system including atherosclerotic vascular disease, myocardial ischemia and reperfusion injury, chronic heart failure, myocarditis, and cardiac allograft rejection. Multiple molecular targets including phosphatidylserine, phosphatidylinositol 3-kinase, and caspases have been targeted by a variety of imaging agents and modalities such as nuclear scintigraphy, PET, MRI, and fluorescent and bioluminescent imaging. Translationally, methods utilizing radiolabeled annexin V have proven promising in several clinical trials of ischemia-reperfusion injury and cardiac allograft rejection. New approaches using novel molecular imaging agents show great potential for the ability to image apoptosis in the research and clinical setting. Ultimately the ability to detect apoptosis noninvasively would help to identify patients for emerging anti-apoptotic therapies and guide clinical management with the aim of maximal myocardial preservation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Jaffer FA, Weissleder R (2005) Molecular imaging in the clinical arena. JAMA 293(7):855–862

    Article  PubMed  CAS  Google Scholar 

  2. Sosnovik DE, Weissleder R (2006) Emerging concepts in molecular MRI. Curr Opin Biotechnol

  3. Weissleder R (2006) Molecular imaging in cancer. Science 312(5777):1168–1171

    Article  PubMed  CAS  Google Scholar 

  4. Jaffer FA, Weissleder R (2004) Seeing within: molecular imaging of the cardiovascular system. Circ Res 94(4):433–445

    Article  PubMed  CAS  Google Scholar 

  5. Narula J, Kietselaer B, Hofstra L (2004) Role of molecular imaging in defining and denying death. J Nucl Cardiol 11(3):349–357

    Article  PubMed  Google Scholar 

  6. Chang GY, Xie X, Wu JC (2006) Overview of stem cells and imaging modalities for cardiovascular diseases. J Nucl Cardiol 13(4):554–569

    Article  PubMed  Google Scholar 

  7. Jaffer FA, Libby P, Weissleder R (2006) Molecular and cellular imaging of atherosclerosis: emerging applications. J Am Coll Cardiol 47(7):1328–1338

    Article  PubMed  CAS  Google Scholar 

  8. Jaffer FA, Sosnovik DE, Nahrendorf M, Weissleder R (2006) Molecular imaging of myocardial infarction. J Mol Cell Cardiol 41(6):921–933

    Article  PubMed  CAS  Google Scholar 

  9. Wickline SA, Neubauer AM, Winter P, Caruthers S, Lanza G (2006) Applications of nanotechnology to atherosclerosis, thrombosis, and vascular biology. Artherioscler Thromb Vasc Biol 26(3):435–441

    Article  CAS  Google Scholar 

  10. Danial NN, Korsmeyer SJ (2004) Cell death: critical control points. Cell 116(2):205–219

    Article  PubMed  CAS  Google Scholar 

  11. Kang PM, Izumo S (2003) Apoptosis in heart: basic mechanisms and implications in cardiovascular diseases. Trends Mol Med 9(4):177–182

    Article  PubMed  CAS  Google Scholar 

  12. Newmeyer DD, Ferguson-Miller S (2003) Mitochondria: releasing power for life and unleashing the machineries of death. Cell 112(4):481–490

    Article  PubMed  CAS  Google Scholar 

  13. Foo RS, Mani K, Kitsis RN (2005) Death begets failure in the heart. J Clin Invest 115(3):565–571

    Article  PubMed  CAS  Google Scholar 

  14. Brauer M (2003) In vivo monitoring of apoptosis. Prog Neuropsychopharmacol Biol Psychiatr 27(2):323–331

    Article  CAS  Google Scholar 

  15. Hatano E, Bradham CA, Stark A, Iimuro Y, Lemasters JJ, Brenner DA (2000) The mitochondrial permeability transition augments Fas-induced apoptosis in mouse hepatocytes. J Biol Chem 275(16):11814–11823

    Article  PubMed  CAS  Google Scholar 

  16. Blankenberg FG, Katsikis PD, Tait JF, Davis RE, Naumovski L, Ohtsuki K, Kopiwoda S, Abrams MJ, Darkes M, Robbins RC, Maecker HT, Strauss HW (1998) In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci USA 95(11):6349–6354

    Article  PubMed  CAS  Google Scholar 

  17. Blankenberg FG, Katsikis PD, Tait JF, Davis RE, Naumovski L, Ohtsuki K, Kopiwoda S, Abrams MJ, Strauss HW (1999) Imaging of apoptosis (programmed cell death) with 99mTc annexin V. J Nucl Med 40(1):184–191

    PubMed  CAS  Google Scholar 

  18. Hofstra L, Liem IH, Dumont EA, Boersma HH, van Heerde WL, Doevendans PA, De Muinck E, Wellens HJ, Kemerink GJ, Reutelingsperger CP, Heidendal GA (2000) Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet 356(9225):209–212

    Article  PubMed  CAS  Google Scholar 

  19. Kown MH, Strauss HW, Blankenberg FG, Berry GJ, Stafford-Cecil S, Tait JF, Goris ML, Robbins RC (2001) In vivo imaging of acute cardiac rejection in human patients using (99 m)technetium labeled annexin V. Am J Transplant 1(3):270–277

    Article  PubMed  CAS  Google Scholar 

  20. Narula J, Acio ER, Narula N, Samuels LE, Fyfe B, Wood D, Fitzpatrick JM, Raghunath PN, Tomaszewski JE, Kelly C, Steinmetz N, Green A, Tait JF, Leppo J, Blankenberg FG, Jain D, Strauss HW (2001) Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nat Med 7(12):1347–1352

    Article  PubMed  CAS  Google Scholar 

  21. Thimister PW, Hofstra L, Liem IH, Boersma HH, Kemerink G, Reutelingsperger CP, Heidendal GA (2003) In vivo detection of cell death in the area at risk in acute myocardial infarction. J Nucl Med 44(3):391–396

    PubMed  Google Scholar 

  22. Bennink RJ, van den Hoff MJ, van Hemert FJ, de Bruin KM, Spijkerboer AL, Vanderheyden JL, Steinmetz N, van Eck-Smit BL (2004) Annexin V imaging of acute doxorubicin cardiotoxicity (apoptosis) in rats. J Nucl Med 45(5):842–848

    PubMed  CAS  Google Scholar 

  23. Kietselaer BL, Reutelingsperger CP, Heidendal GA, Daemen MJ, Mess WH, Hofstra L, Narula J (2004) Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis. N Engl J Med 350(14):1472–1473

    Article  PubMed  CAS  Google Scholar 

  24. Peker C, Sarda-Mantel L, Loiseau P, Rouzet F, Nazneen L, Martet G, Vrigneaud JM, Meulemans A, Saumon G, Michel JB, Le Guludec D (2004) Imaging apoptosis with (99m)Tc-annexin-V in experimental subacute myocarditis. J Nucl Med 45(6):1081–1086

    PubMed  CAS  Google Scholar 

  25. Hartung D, Sarai M, Petrov A, Kolodgie F, Narula N, Verjans J, Virmani R, Reutelingsperger C, Hofstra L, Narula J (2005) Resolution of apoptosis in atherosclerotic plaque by dietary modification and statin therapy. J Nucl Med 46(12):2051–2056

    PubMed  CAS  Google Scholar 

  26. Johnson LL, Schofield L, Donahay T, Narula N, Narula J (2005) 99mTc-annexin V imaging for in vivo detection of atherosclerotic lesions in porcine coronary arteries. J Nucl Med 46(7):1186–1193

    PubMed  Google Scholar 

  27. Isobe S, Tsimikas S, Zhou J, Fujimoto S, Sarai M, Branks MJ, Fujimoto A, Hofstra L, Reutelingsperger CP, Murohara T, Virmani R, Kolodgie FD, Narula N, Petrov A, Narula J (2006) Noninvasive imaging of atherosclerotic lesions in apolipoprotein E-deficient and low-density-lipoprotein receptor-deficient mice with annexin A5. J Nucl Med 47(9):1497–1505

    PubMed  CAS  Google Scholar 

  28. Sarda-Mantel L, Michel JB, Rouzet F, Martet G, Louedec L, Vanderheyden JL, Hervatin F, Raguin O, Vrigneaud JM, Khaw BA, Le Guludec D (2006) (99 m)Tc-annexin V and (111)In-antimyosin antibody uptake in experimental myocardial infarction in rats. Eur J Nucl Med Mol Imaging 33(3):239–245

    Article  PubMed  CAS  Google Scholar 

  29. Grierson JR, Yagle KJ, Eary JF, Tait JF, Gibson DF, Lewellen B, Link JM, Krohn KA (2004) Production of [F-18]fluoroannexin for imaging apoptosis with PET. Bioconjug Chem 15(2):373–379

    Article  PubMed  CAS  Google Scholar 

  30. Keen HG, Dekker BA, Disley L, Hastings D, Lyons S, Reader AJ, Ottewell P, Watson A, Zweit J (2005) Imaging apoptosis in vivo using 124I-annexin V and PET. Nucl Med Biol 32(4):395–402

    Article  PubMed  CAS  Google Scholar 

  31. Cauchon N, Langlois R, Rousseau JA, Tessier G, Cadorette J, Lecomte R, Hunting DJ, Pavan RA, Zeisler SK, van Lier JE (2006) PET imaging of apoptosis with (64)Cu-labeled streptavidin following pretargeting of phosphatidylserine with biotinylated annexin-V. Eur J Nucl Med Mol Imaging

  32. Sosnovik DE, Schellenberger EA, Nahrendorf M, Novikov MS, Matsui T, Dai G, Reynolds F, Grazette L, Rosenzweig A, Weissleder R, Josephson L (2005) Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle. Magn Reson Med 54(3):718–724

    Article  PubMed  Google Scholar 

  33. Hiller KH, Waller C, Nahrendorf M, Bauer WR, Jakob PM (2006) Assessment of cardiovascular apoptosis in the isolated rat heart by magnetic resonance molecular imaging. Mol Imaging 5(2):115–121

    PubMed  Google Scholar 

  34. Petrovsky A, Schellenberger E, Josephson L, Weissleder R, Bogdanov A Jr (2003) Near-infrared fluorescent imaging of tumor apoptosis. Cancer Res 63(8):1936–1942

    PubMed  CAS  Google Scholar 

  35. Ntziachristos V, Schellenberger EA, Ripoll J, Yessayan D, Graves E, Bogdanov A Jr, Josephson L, Weissleder R (2004) Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate. Proc Natl Acad Sci USA 101(33):12294–12299

    Article  PubMed  CAS  Google Scholar 

  36. Zhao M, Zhu X, Ji S, Zhou J, Ozker KS, Fang W, Molthen RC, Hellman RS (2006) 99mTc-labeled C2A domain of synaptotagmin I as a target-specific molecular probe for noninvasive imaging of acute myocardial infarction. J Nucl Med 47(8):1367–1374

    PubMed  CAS  Google Scholar 

  37. Zhao M, Beauregard DA, Loizou L, Davletov B, Brindle KM (2001) Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nat Med 7(11):1241–1244

    Article  PubMed  CAS  Google Scholar 

  38. Zhou D, Chu W, Rothfuss J, Zeng C, Xu J, Jones L, Welch MJ, Mach RH (2006) Synthesis, radiolabeling, and in vivo evaluation of an 18F-labeled isatin analog for imaging caspase-3 activation in apoptosis. Bioorg Med Chem Lett 16(19):5041–5046

    Article  PubMed  CAS  Google Scholar 

  39. Messerli SM, Prabhakar S, Tang Y, Shah K, Cortes ML, Murthy V, Weissleder R, Breakefield XO, Tung CH (2004) A novel method for imaging apoptosis using a caspase-1 near-infrared fluorescent probe. Neoplasia 6(2):95–105

    Article  PubMed  CAS  Google Scholar 

  40. Laxman B, Hall DE, Bhojani MS, Hamstra DA, Chenevert TL, Ross BD, Rehemtulla A (2002) Noninvasive real-time imaging of apoptosis. Proc Natl Acad Sci USA 99(26):16551–16555

    Article  PubMed  CAS  Google Scholar 

  41. Fadok VA, Savill JS, Haslett C, Bratton DL, Doherty DE, Campbell PA, Henson PM (1992) Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol 149(12):4029–4035

    PubMed  CAS  Google Scholar 

  42. van Heerde WL, Robert-Offerman S, Dumont E, Hofstra L, Doevendans PA, Smits JF, Daemen MJ, Reutelingsperger CP (2000) Markers of apoptosis in cardiovascular tissues: focus on Annexin V. Cardiovasc Res 45(3):549–559

    Article  PubMed  Google Scholar 

  43. Schellenberger EA, Sosnovik D, Weissleder R, Josephson L (2004) Magneto/optical annexin V, a multimodal protein. Bioconjug Chem 15(5):1062–1067

    Article  PubMed  CAS  Google Scholar 

  44. Davletov BA, Sudhof TC (1993) A single C2 domain from synaptotagmin I is sufficient for high affinity Ca2+/phospholipid binding. J Biol Chem 268(35):26386–26390

    PubMed  CAS  Google Scholar 

  45. Schellenberger EA, Reynolds F, Weissleder R, Josephson L (2004) Surface-functionalized nanoparticle library yields probes for apoptotic cells. Chembiochem 5(3):275–279

    Article  PubMed  CAS  Google Scholar 

  46. Quinti L, Weissleder R, Tung CH (2006) A fluorescent nanosensor for apoptotic cells. Nano Lett 6(3):488–490

    Article  PubMed  CAS  Google Scholar 

  47. Aloya R, Shirvan A, Grimberg H, Reshef A, Levin G, Kidron D, Cohen A, Ziv I (2006) Molecular imaging of cell death in vivo by a novel small molecule probe. Apoptosis 11(12):2089–2101

    Article  PubMed  Google Scholar 

  48. Fujio Y, Nguyen T, Wencker D, Kitsis RN, Walsh K (2000) Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 101(6):660–667

    PubMed  CAS  Google Scholar 

  49. Wymann MP, Bulgarelli-Leva G, Zvelebil MJ, Pirola L, Vanhaesebroeck B, Waterfield MD, Panayotou G (1996) Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction. Mol Cell Biol 16(4):1722–1733

    PubMed  CAS  Google Scholar 

  50. Yuan H, Luo J, Field S, Weissleder R, Cantley L, Josephson L (2005) Synthesis and activity of C11-modified wortmannin probes for PI3 kinase. Bioconjug Chem 16(3):669–675

    Article  PubMed  CAS  Google Scholar 

  51. Gross S, Piwnica-Worms D (2005) Spying on cancer: molecular imaging in vivo with genetically encoded reporters. Cancer Cell 7(1):5–15

    PubMed  CAS  Google Scholar 

  52. Bhojani MS, Hamstra DA, Chang DC, Coppola JM, Khan AP, Reddy GR, Ross BD, Rehemtulla A (2006) Imaging of proteolytic activity using a conditional cell surface receptor. Mol Imaging 5(2):129–137

    PubMed  Google Scholar 

  53. Lin J, Zhang Z, Yang J, Zeng S, Liu BF, Luo Q (2006) Real-time detection of caspase-2 activation in a single living HeLa cell during cisplatin-induced apoptosis. J Biomed Opt 11(4):049801

    Article  Google Scholar 

  54. Kim K, Lee M, Park H, Kim JH, Kim S, Chung H, Choi K, Kim IS, Seong BL, Kwon IC (2006) Cell-permeable and biocompatible polymeric nanoparticles for apoptosis imaging. J Am Chem Soc 128(11):3490–3491

    Article  PubMed  CAS  Google Scholar 

  55. Liu JJ, Wang W, Dicker DT, El-Deiry WS (2005) Bioluminescent imaging of TRAIL-induced apoptosis through detection of caspase activation following cleavage of DEVD-aminoluciferin. Cancer Biol Ther 4(8):885–892

    Article  PubMed  CAS  Google Scholar 

  56. Stefflova K, Chen J, Li H, Zheng G (2006) Targeted photodynamic therapy agent with a built-in apoptosis sensor for in vivo near-infrared imaging of tumor apoptosis triggered by its photosensitization in situ. Mol Imaging 5(4):520–532

    PubMed  Google Scholar 

  57. Bauer C, Bauder-Wuest U, Mier W, Haberkorn U, Eisenhut M (2005) 131I-labeled peptides as caspase substrates for apoptosis imaging. J Nucl Med 46(6):1066–1074

    PubMed  CAS  Google Scholar 

  58. Ramlawi B, Feng J, Mieno S, Szabo C, Zsengeller Z, Clements R, Sodha N, Boodhwani M, Bianchi C, Sellke FW (2006) Indices of apoptosis activation after blood cardioplegia and cardiopulmonary bypass. Circulation 114(1 Suppl):I257–I263

    PubMed  Google Scholar 

  59. Rossi ML, Marziliano N, Merlini PA, Bramucci E, Canosi U, Belli G, Parenti DZ, Mannucci PM, Ardissino D (2004) Different quantitative apoptotic traits in coronary atherosclerotic plaques from patients with stable angina pectoris and acute coronary syndromes. Circulation 110(13):1767–1773

    Article  PubMed  Google Scholar 

  60. Kockx MM, Knaapen MW (2006) Pathological changes in the coronary arteries in the acute coronary syndromes. Heart 92(11):1557–1558

    Article  PubMed  CAS  Google Scholar 

  61. Bjorkerud S, Bjorkerud B (1996) Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am J Pathol 149(2):367–380

    PubMed  CAS  Google Scholar 

  62. Libby P (2002) Inflammation in atherosclerosis. Nature 420(6917):868–874

    Article  PubMed  CAS  Google Scholar 

  63. Kolodgie FD, Petrov A, Virmani R, Narula N, Verjans JW, Weber DK, Hartung D, Steinmetz N, Vanderheyden JL, Vannan MA, Gold HK, Reutelingsperger CP, Hofstra L, Narula J (2003) Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque. Circulation 108(25):3134–3139

    Article  PubMed  CAS  Google Scholar 

  64. Bolli R, Becker L, Gross G, Mentzer R Jr, Balshaw D, Lathrop DA (2004) Myocardial protection at a crossroads: the need for translation into clinical therapy. Circ Res 95(2):125–134

    Article  PubMed  CAS  Google Scholar 

  65. Anversa P, Cheng W, Liu Y, Leri A, Redaelli G, Kajstura J (1998) Apoptosis and myocardial infarction. Basic Res Cardiol 93 (Suppl 3):8–12

    Article  PubMed  Google Scholar 

  66. Olivetti G, Quaini F, Sala R, Lagrasta C, Corradi D, Bonacina E, Gambert SR, Cigola E, Anversa P (1996) Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol 28(9):2005–2016

    Article  PubMed  CAS  Google Scholar 

  67. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL (1994) Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94(4):1621–1628

    Article  PubMed  CAS  Google Scholar 

  68. Garg S, Hofstra L, Reutelingsperger C, Narula J (2003) Apoptosis as a therapeutic target in acutely ischemic myocardium. Curr Opin Cardiol 18(5):372–377

    Article  PubMed  Google Scholar 

  69. Dumont EA, Reutelingsperger CP, Smits JF, Daemen MJ, Doevendans PA, Wellens HJ, Hofstra L (2001) Real-time imaging of apoptotic cell-membrane changes at the single-cell level in the beating murine heart. Nat Med 7(12):1352–1355

    Article  PubMed  CAS  Google Scholar 

  70. Taki J, Higuchi T, Kawashima A, Tait JF, Kinuya S, Muramori A, Matsunari I, Nakajima K, Tonami N, Strauss HW (2004) Detection of cardiomyocyte death in a rat model of ischemia and reperfusion using 99mTc-labeled annexin V. J Nucl Med 45(9):1536–1541

    PubMed  CAS  Google Scholar 

  71. Dumont EA, Hofstra L, van Heerde WL, van den Eijnde S, Doevendans PA, DeMuinck E, Daemen MA, Smits JF, Frederik P, Wellens HJ, Daemen MJ, Reutelingsperger CP (2000) Cardiomyocyte death induced by myocardial ischemia and reperfusion: measurement with recombinant human annexin-V in a mouse model. Circulation 102(13):1564–1568

    PubMed  CAS  Google Scholar 

  72. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski S, Reed JC, Anversa P (1997) Apoptosis in the failing human heart. N Engl J Med 336(16):1131–1141

    Article  PubMed  CAS  Google Scholar 

  73. Guerra S, Leri A, Wang X, Finato N, Di Loreto C, Beltrami CA, Kajstura J, Anversa P (1999) Myocyte death in the failing human heart is gender dependent. Circ Res 85(9):856–866

    PubMed  CAS  Google Scholar 

  74. Saraste A, Pulkki K, Kallajoki M, Heikkila P, Laine P, Mattila S, Nieminen MS, Parvinen M, Voipio-Pulkki LM (1999) Cardiomyocyte apoptosis and progression of heart failure to transplantation. Eur J Clin Invest 29(5):380–386

    Article  PubMed  CAS  Google Scholar 

  75. Hayakawa Y, Chandra M, Miao W, Shirani J, Brown JH, Dorn GW 2nd, Armstrong RC, Kitsis RN (2003) Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Galpha(q) transgenic mice. Circulation 108(24):3036–3041

    Article  PubMed  CAS  Google Scholar 

  76. Adams JW, Sakata Y, Davis MG, Sah VP, Wang Y, Liggett SB, Chien KR, Brown JH, Dorn GW 2nd (1998) Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc Natl Acad Sci USA 95(17):10140–10145

    Article  PubMed  CAS  Google Scholar 

  77. Sosnovik D, Nahrendorf M, Grazette L, Reynolds F, Rosenzweig A, Weissleder R, Josephson L (2005) Molecular imaging of low levels of cardiomyocyte apoptosis with a targeted magneto-fluorescent contrast agent. In: American Heart Association Scientific Sessions Series. Molecular imaging of low levels of cardiomyocyte apoptosis with a targeted magneto-fluorescent contrast agent

  78. Petillot P, Lahorte C, Bonanno E, Signore A, Lancel S, Marchetti P, Vallet B, Slegers G, Neviere R (2007) Annexin V detection of lipopolysaccharide-induced cardiac apoptosis. Shock 27(1):69–74

    Article  PubMed  CAS  Google Scholar 

  79. Yeh ET, Tong AT, Lenihan DJ, Yusuf SW, Swafford J, Champion C, Durand JB, Gibbs H, Zafarmand AA, Ewer MS (2004) Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation 109(25):3122–3131

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Support Sources: 1. National Institutes of Health, Bethesda, Maryland: (a) NIH K08 HL079984 (DS); (b) NIH UO1-HL080731 (FJ, DS, RW); 2. Donald W. Reynolds Foundation, Las Vegas, Nevada (FJ, RW).

Author information

Authors and Affiliations

  1. Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, 149 13th St., 5th floor, Boston, MA, 02129, USA

    Ethan Chauncey Korngold, Farouc Amin Jaffer, Ralph Weissleder & David Edwin Sosnovik

  2. Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA

    Ethan Chauncey Korngold, Farouc Amin Jaffer & David Edwin Sosnovik

Authors
  1. Ethan Chauncey Korngold
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Farouc Amin Jaffer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ralph Weissleder
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David Edwin Sosnovik
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David Edwin Sosnovik.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Korngold, E.C., Jaffer, F.A., Weissleder, R. et al. Noninvasive imaging of apoptosis in cardiovascular disease. Heart Fail Rev 13, 163–173 (2008). https://doi.org/10.1007/s10741-007-9068-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10741-007-9068-4

Keywords

Search

Navigation